Skip to content

A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery

China Observational Study of Smoking Cessation Patterns in Patients Undergoing Lung Surgery (CHAMPION Study)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04313361
Acronym
CHAMPION
Enrollment
290
Registered
2020-03-18
Start date
2020-05-06
Completion date
2021-12-09
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Brief summary

The purpose of this study is to assess the current smoking status and smoking cessation attempts among smokers or recent smoking quitters during the perioperative period, to describe postoperative pulmonary complications (PPCs) and other postoperative complications (PCs) following a lung surgery, and to describe the smoking cessation methods and services patients received from their health care professionals (HCPs) and participant's satisfaction among participants with lung cancer, chronic obstructive pulmonary disorder (COPD), a pulmonary lesion (example, nodule, or ground glass opacity) or other pulmonary conditions who are admitted to the thoracic surgical unit of the participating hospitals in China.

Interventions

OTHERNo intervention

No drug will be administered as part of this study.

Sponsors

Johnson & Johnson (China) Investment Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Participants who have been scheduled for an elective lung surgery by the treating physician's judgement, due to the following conditions: known lung cancer, COPD, a pulmonary lesion (example. nodule, ground glass opacity) or other pulmonary conditions * Smokers who are or were smoking on average no fewer than 5 cigarettes per day for equal or more than 3 years within 3 months prior to the scheduled surgery, or recent smoking quitters with a history of smoking on average no fewer than 5 cigarettes per day for equal or more than 3 years, who quit smoking between 3 months and 5 years prior to the scheduled surgery * Being willing to participate the study and sign the participant informed consent form (ICF)

Exclusion criteria

* Participants who have emergency lung surgery due to accident or injury * Participants are not likely to be able to complete the 6-month follow-up after the lung surgery

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Smokers and Recent Smoking Quitters at Baseline Prior to the SurgeryBaseline Prior to the SurgeryPercentage of smokers and recent smoking quitters at baseline prior to the surgery will be reported.
Smoking Dependence Among Smokers as Measured by Fagerstrom Test of Nicotine Dependence (FTND) Scale at Baseline Prior to the SurgeryBaseline Prior to the SurgeryLevel of smoking dependence will be measured by FTND Scale in the participant's questionnaire. FTND is a 6-item self-report measure of nicotine dependence derived from the Fagerström Tolerance Questionnaire, which comprises yes/no options (scored from 0 to 1) and multiple-choice items (scored from 0 to 3). The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the participant's physical dependence on nicotine.
Smoking Dependence Among Smokers as Measured by FTND Scale at Month 1 Post-surgeryMonth 1 post-surgeryLevel of smoking dependence will be measured by FTND Scale in the participant's questionnaire. FTND is a 6-item self-report measure of nicotine dependence derived from the Fagerström Tolerance Questionnaire, which comprises yes/no options (scored from 0 to 1) and multiple-choice items (scored from 0 to 3). The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the participant's physical dependence on nicotine.
Smoking Dependence Among Smokers as Measured by FTND Scaleat Month 3 Post-surgeryMonth 3 post-surgeryLevel of smoking dependence will be measured by FTND Scale in the participant's questionnaire. FTND is a 6-item self-report measure of nicotine dependence derived from the Fagerström Tolerance Questionnaire, which comprises yes/no options (scored from 0 to 1) and multiple-choice items (scored from 0 to 3). The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the participant's physical dependence on nicotine.
Smoking Dependence Among Smokers as Measured by FTND Scaleat Month 6 Post-surgeryMonth 6 post-surgeryLevel of smoking dependence will be measured by FTND Scale in the participant's questionnaire. FTND is a 6-item self-report measure of nicotine dependence derived from the Fagerström Tolerance Questionnaire, which comprises yes/no options (scored from 0 to 1) and multiple-choice items (scored from 0 to 3). The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the participant's physical dependence on nicotine.
Number of Smoking Cessation Attempts at Baseline Prior to the SurgeryBaseline prior to the surgeryNumber of smoking cessation attempts at baseline prior to the surgery will be reported.
Number of Smoking Cessation Attempts at Month 1 Post-surgeryMonth 1 post-surgeryNumber of smoking cessation attempts at Month 1 post-surgery will be reported.
Number of Smoking Cessation Attempts at Month 3 Post-surgeryMonth 3 post-surgeryNumber of smoking cessation attempts at Month 3 post-surgery will be reported.
Number of Smoking Cessation Attempts at Month 6 Post-surgeryMonth 6 post-surgeryNumber of smoking cessation attempts at Month 6 post-surgery will be reported.
Number of Participants who Used Methods and Medications for Smoking Cessation at BaselineBaselineNumber of participants who used prior methods and medications for smoking cessation at baseline will be reported.
Number of Participants who Used Current Methods and Medications for Smoking Cessation at Month 1 Post-surgeryMonth 1 post-surgeryNumber of participants who used current methods or medication for smoking cessation at Month 1 post-surgery will be reported.
Number of Participants who Used Current Methods and Medications for Smoking Cessation at Month 3 Post-surgeryMonth 3 post-surgeryNumber of participants who used current methods or medication for smoking cessation at Month 3 post-surgery will be reported.
Number of Participants who Used Prior Methods and Medications for Smoking Cessation at Month 6 Post-surgeryMonth 6 post-surgeryNumber of participants who used current methods or medication for smoking cessation at Month 6 post-surgery will be reported.
Percentage of Participants Using Nicotine Replacement Therapy (NRTs) at Baseline Prior to SurgeryBaseline prior to surgeryPercentage of participants using NRTs, types of NRTs used and perceived effectiveness, at baseline prior to surgery will be reported.
Percentage of Participants Using NRTs at Month 1 Post-surgeryMonth 1 post-surgeryPercentage of participants using NRTs, types of NRTs used and perceived effectiveness, at Month 1 post surgery will be reported.
Percentage of Participants Using NRTs at Month 3 Post-surgeryMonth 3 post-surgeryPercentage of participants using NRTs, types of NRTs used and perceived effectiveness, at Month 3 post surgery will be reported.
Percentage of Participants Using NRTs, Types of NRTs Used and Perceived Effectiveness at Month 6 Post-surgeryMonth 6 post-surgeryPercentage of participants using NRTs, types of NRTs used and perceived effectiveness, at Month 6 post surgery will be reported.
Percentage of Participants with Self-reported Smoking Abstinence and Point Prevalence at Month 1 Post-surgeryMonth 1 post-surgeryPercentage of participants with self-reported smoking abstinence and 7-days/30-day point prevalence of smoking at Month 1 post-surgery will be reported.
Percentage of Participants with Self-reported Smoking Abstinence and Point Prevalence at Month 3 Post-surgeryMonth 3 post-surgeryPercentage of participants with self-reported smoking abstinence and point prevalence of smoking at Month 3 post-surgery will be reported.
Percentage of Participants with Self-reported Smoking Abstinence and Point Prevalence at Month 6 Post-surgeryMonth 6 post-surgeryPercentage of participants with self-reported smoking abstinence and point prevalence of smoking at Month 6 post-surgery will be reported.
Percentage of Participants with Smoking Relapse at Month 1 Post-surgeryMonth 1 post-surgeryPercentage of participants with smoking relapse at Month 1 post-surgery will be reported.
Percentage of Participants with Smoking Relapse at Month 3 Post-surgeryMonth 3 post-surgeryPercentage of participants with smoking relapse at Month 3 post-surgery will be reported.
Percentage of Participants with Smoking Relapse at Month 6 Post-surgeryMonth 6 post-surgeryPercentage of participants with smoking relapse at Month 6 post-surgery will be reported.
Overall Incidence of Postoperative Complications (PCs) and Postoperative Pulmonary Complications (PPCs) Post-surgery (at 1 Day Prior to Discharge)and by Baseline Smoking StatusAt 1 day prior to dischargeOverall incidence of PCs and PPCs post-surgery (at 1 day prior to discharge) and by baseline smoking status will be reported.
Overall Incidence of PCs and PPCs Post-surgery (Within 2 Weeks After Surgery) and by Baseline Smoking StatusWithin 2 weeks after surgeryOverall incidence of PCs and PPCs post-surgery (within 2 weeks after surgery) and by baseline smoking status will be reported.
Overall Incidence of PCs and PPCs Post-surgery (Within 1 Month Post-surgery) and by Baseline Smoking StatusWithin 1 month post-surgeryOverall incidence of PCs and PPCs post-surgery (within 1 month post-surgery) and by baseline smoking status will be reported.
Overall Incidence of PCs and PPCs Post-surgery (Within 3 Months Post-surgery) and by Baseline Smoking StatusWithin 3 months post-surgeryOverall incidence of PCs and PPCs post-surgery (within 3 months post-surgery) and by baseline smoking status will be reported.
Overall Incidence of PCs and PPCs Post-surgery (Within 6 Months Post-surgery) and by Baseline Smoking StatusWithin 6 months post-surgeryOverall incidence of PCs and PPCs post-surgery (within 6 months post-surgery) and by baseline smoking status will be reported.
Percentage of Participants who Received Advice from HCPs to Quit Smoking at Baseline Prior to SurgeryBaseline prior to surgeryPercentage of participants who received advice from HCPs to quit smoking at baseline prior to surgery will be reported.
Percentage of Participants who Received Advice from HCPs to Quit Smoking at Month 1 Post-surgeryMonth 1 post-surgeryPercentage of participants who received advice from HCPs to quit smoking at Month 1 post-surgery will be reported.
Percentage of Participants who Received Advice from HCPs to Quit Smoking at Month 3 post-surgeryMonth 3 post-surgeryPercentage of participants who received advice from HCPs to quit smoking at Month 3 post-surgery will be reported.
Percentage of Participants who Received Advice from HCPs to Quit Smoking at Month 6 post-surgeryMonth 6 post-surgeryPercentage of participants who received advice from HCPs to quit smoking at Month 6 post-surgery will be reported.
Percentage of Specific Smoking Cessation Methods and Service Participants Received from HCPs at Baseline Prior to SurgeryBaseline prior to surgeryPercentage of specific smoking cessation methods and service participants received from HCPs at baseline prior to surgery will be reported.
Percentage of Specific Smoking Cessation Methods and Service Participants Received from HCPs at Month 3 post-surgeryMonth 3 post-surgeryPercentage of specific smoking cessation methods and service participants received from HCPs at Month 3 post-surgery will be reported.
Percentage of Specific Smoking Cessation Methods and Service Participants Received from HCPs at Month 6 post-surgeryMonth 6 post-surgeryPercentage of specific smoking cessation methods and service participants received from HCPs at Month 6 post-surgery will be reported.
Percentage of Participant's Satisfaction on the Smoking Cessation Methods Received from HCPs at Baseline Prior to SurgeryBaseline prior to surgeryPercentage of participant's satisfaction on the smoking cessation methods received from HCPs at baseline prior to surgery will be reported.
Percentage of Participant's Satisfaction on the Smoking Cessation Methods Received from HCPs at Month 1 Post-surgeryMonth 1 post-surgeryPercentage of participant's satisfaction on the smoking cessation methods received from HCPs at Month 1 post-surgery will be reported.
Percentage of Participant's Satisfaction on the Smoking Cessation Methods Received from HCPs at Month 3 Post-surgeryMonth 3 post-surgeryPercentage of participant's satisfaction on the smoking cessation methods received from HCPs at Month 3 post-surgery will be reported.
Percentage of Participant's Satisfaction on the Smoking Cessation Methods Received from HCPs at Month 6 Post-surgeryMonth 6 post-surgeryPercentage of participant's satisfaction on the smoking cessation methods received from HCPs at Month 6 post-surgery will be reported.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026